Showing 5191-5200 of 6808 results for "".
- Cytrellis Taps New CTOhttps://practicaldermatology.com/news/cytrellis-taps-new-cto/2461695/Dr. Shiv Sabesan is Cytrellis Biosystems’ Chief Technology Officer. In his new role, Dr. Sabesan will lead the company's strategy as it continues to advance its proprietary ellacor Micro-Coring technology and expand indications. The technology was
- Dr. Suneel Chilukuri Named Hydrinity Accelerated Skin Science’s Chief Medical Advisorhttps://practicaldermatology.com/news/dr-suneel-chilukuri-named-hydrinity-accelerated-skin-sciences-chief-medical-advisor/2461692/Suneel Chilukuri, MD, is Hydrinity Accelerated Skin Science’s new Chief Medical Advisor. In this role, Dr. Chilukuri will chair the Hydrinity Accelerated Skin Science Medical Advisory Board. He will aid product development as well as develop and oversee all clinica
- Lilly's Lebrikizumab Improves AD on Face, Handshttps://practicaldermatology.com/news/lillys-lebrikizumab-improves-ad-on-face-hands/2461689/Up to 73% of atopic dermatitis patients (AD) receiving lebrikizumab showed Improved or cleared skin on face or hands at 16 weeks, a new study shows. Lebrikizumab is an investigational high-affinity and potent IL-13 inhibitor being studied in adult and adolescent patients 12 y
- Arctiva Eczema Cream Spells Relief for 91% of Patientshttps://practicaldermatology.com/news/study-arctiva-eczema-cream-spells-relief-for-91-of-patients/2461688/Fully 91% of participants reported improvement in eczema irritation using proprietary Arctiva Eczema Cream, a new study shows. Arctiva Eczema Cream features Hydrosurf glycolipid technology—a blend of fermented ingredients with origins from Antarctica. It is combined with 1% C
- Aquavit News: Company Files Investigational New Drug Application for Dermatoxhttps://practicaldermatology.com/news/aquavit-news-company-files-investigational-new-drug-application-for-dermatox/2461687/Aquavit has filed an Investigational New Drug Application with the U.S Food and Drug Administration (FDA) for Dermatox (aqubotulinumtoxinA), their intradermal injection of botulinum toxin. AqubotulinumtoxinA has already received regulatory approvals in Asia, Sou
- Cetaphil Teams Up with Makeup Artist Alexx Mayo for Lizzo's Upcoming Tourhttps://practicaldermatology.com/news/cetaphil-teams-up-with-makeup-artist-alexx-mayo-for-lizzos-upcoming-tour/2461684/Cetaphil cleansers and moisturizers will be an integral part of Lizzo’s skin prep and glam during her upcoming "Special" tour courtesy of makeup artist Alexx Mayo. The brand will enlist Alexx Mayo to create social content showcasing how he relies on
- Galderma Survey Debunks Filler Mythshttps://practicaldermatology.com/news/galderma-survey-debunks-filler-myths/2461668/Forty percent of people say they would discourage others from using facial injectables to reduce wrinkles or provide volume, and 34% said they believed the results of such treatments look fake and unnatural, according to a new poll sponsored by Galderma. Despite these views, the same re
- Smart Wound Dressing Can Spot Infection Earlyhttps://practicaldermatology.com/news/smart-wound-dressing-can-spot-infection-early/2461666/A nanocellulose wound dressing that can reveal early signs of infection without interfering with the healing process has been developed by researchers at Linköping University, Sweden. The study is published in Materials Today Bio. Researchers at Link&o
- AARS Shines Light on Antibiotic Resistance During Rosacea Awareness Monthhttps://practicaldermatology.com/news/aars-shines-light-on-antibiotic-resistance-during-rosacea-awareness-month/2461664/The American Acne and Rosacea Society (AARS) is calling on patients and prescribers to ensure appropriate use of antibiotics to manage rosacea during Rosacea Awareness Month. “It has been well known for many years that dermatologists prescribe more antibiotics per clinician than p
- FDA Clears New Underarm Sweat Control Patchhttps://practicaldermatology.com/news/fda-clears-new-underarm-sweat-control-patch/2461660/The U.S. Food and Drug Administration (FDA) has cleared cleared Brella, the first 3-Minute SweatControl Patch to significantly reduce excessive underarm sweating in adults with primary axillary hyperhidrosis. The Brella SweatControl Patch provide